Trials / Completed
CompletedNCT00712868
Acceptability of Lactacyd Femina
Safety Dermatological Evaluation: Acceptability With Gynaecological Follow up Lactacyd Femina
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 559 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the safety and acceptability of the gynaecological formulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lactic acid | Once a day |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2008-07-10
- Last updated
- 2009-07-20
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00712868. Inclusion in this directory is not an endorsement.